Ingredion Inc (INGR) Form 10-Q — Aug 7, 2026
Ingredion's second-quarter 2026 net sales rose 1 percent to $1,850 million, but net income attributable to Ingredion fell to $114 million ($1.78 diluted EPS) from $196 million ($2.99) a year ago, and year-to-date operating income dropped 29 percent to $391 million. The decline reflected higher manufacturing costs including the thermal event at the Argo facility, $45 million of restructuring and impairment charges tied to the Cabo, Brazil facility closure, and $47 million of acquisition-related foreign exchange hedging losses.
Key figures
- Eps
- 1.78
- Revenue
- 1850000000
- Net Income
- 114000000
- Total Debt
- 1783000000
- Debt Amount
- up to approximately $4.2 billion of additional indebtedness expected for the Tate & Lyle acquisition
- Total Assets
- 8070000000
- Cash Position
- 948000000
- Deal Value Usd
- approximately $3.5 billion (£2.7 billion) for Tate & Lyle
- Interest Rate
- 4
- Shares Outstanding
- 63063979
- Ddtl facility
- $1,475M delayed draw term loan
- Ytd net sales
- $3,642M (vs $3,646M YTD 2025)
- Bridge facility
- $4,225M original commitment, reduced to $2,750M
- Ytd diluted eps
- 4.01
- Q2 net sales yoy
- +1% ($1,850M vs $1,833M)
- Fx hedge notional
- £2,793 million GBP options; $57M paid June 5, 2026; expire February 8, 2028
- Share buyback ytd
- 120 thousand shares at net cost of $14M; 7.3M shares remaining under 8.0M authorization
- Quarterly dividend
- $0.82 per share in 2026 (vs $0.80 in 2025)
- Available liquidity
- $3.9 billion excluding Tate & Lyle acquisition facilities
- Ytd operating income
- $391M, down 29% YoY
- Effective tax rate q2
- 33.7% (vs 23.6% Q2 2025)
- Pakistan gain on sale
- $44M; retained ~20% stake recorded at $65M fair value
- Operating cash flow ytd
- $123M (vs $262M YTD 2025)
- Estimated post close debt
- up to approximately $6.0 billion
- Q2 diluted eps prior year
- 2.99
- Tate lyle retention awards
- up to £18 million aggregate for ~100 key employees
- Ytd net income attributable
- $256M (vs $393M YTD 2025)
- Pakistan sale gross proceeds
- approximately $165M ($127M cash after deconsolidation)
- Acquisition related costs ytd
- $53M, including $47M of FX hedging losses in Financing costs
- Capex guidance remainder 2026
- $450M-$490M
- Acquisition cash consideration
- 595 pence per Tate & Lyle ordinary share, plus permitted dividends up to 13.2p final and 6.8p interim
- Restructuring impairment charges ytd
- $56M, primarily Cabo, Brazil facility closure
Price after filing
Close on the filing date to close N calendar days later (from $103.29). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.